Do you have PCOS patients who are looking for a new treatment option? If so, please let them know about the LILACS Study—a clinical trial evaluating the effectiveness of the Lilli App, a lifestyle-based digital tool designed to address insulin resistance, the root cause of many PCOS symptoms. This study aims to support FDA clearance of the Lilli App as a treatment for insulin resistance in patients with PCOS.
What is the LILACS Study?
- An 8-week randomized waitlist-control study
- Focused on helping patients with PCOS manage symptoms through a science-backed, app-based Low Insulin Lifestyle program
Who Can Participate?
- Women with a formal PCOS diagnosis
- Patients aged 18-45 years
- Patients motivated to try a non-medication, lifestyle-based approach
How to Join:
Patients can visit Lilacs-Study.com to learn more and complete a short interest form to see if they qualify.
Your referral can help provide a new, innovative option for patients struggling with PCOS symptoms. Together, we can advance care and improve outcomes for women who need it most.
